publication . Article . 2016

Aphasia, Just a Neurological Disorder?

Mehmet Ozdemir;
Open Access English
  • Published: 01 Feb 2016 Journal: Journal of Clinical and Analytical Medicine, volume 6, issue 155, pages 704-706 (issn: 1309-0720, eissn: 1309-2014, Copyright policy)
  • Publisher: Derman Medical Publishing
Abstract
Hashimoto%u2019s encephalopathy (HE) is a rare disorder associated with autoimmune thyroiditis. Etiology of HE is not completely understood. High levels of serum antithyroid antibodies are seen in HE. Presentation with otoimmune thyroiditis, cognitive impairment, psychiatric and neurologic symptoms and absence of bacterial or viral enfections are characteristics of HE. HE is a steroid responsive encephalopathy. 60 years old male patient admitted to hospital with forget fulness continuing for 9 months and speech loss starting 2 days ago. Strong positivity of antithyroid antibodies increases the odds for HE. Thyroid function tests showed severe hypothyroidism. Ele...
Persistent Identifiers
Subjects
Medical Subject Headings: endocrine system diseasesendocrine system
free text keywords: Hashimotos encephalopathy, Aphasia, Neurological Disorder, lcsh:Medicine, lcsh:R

1. Brain L, Jellinek EH, Ball K. Hashimoto's disease and encephalopathy. Lancet 1966;2(7462):512-4.

2. Archambaud F, Calinat S, Regouby Y. Hashimoto encephalopathy: analysis of four cases. Rev Me´d Interne. 2001;22(7):653-9.

3. Chong CS, Leung JL, Wong IH. Presenile dementia: a case of Hashimoto's encephalopathy. East Asian Arch Psychiatry 2011; 21(1): 32-6.

4. Chong JY, Rowland LP, Utiger RD. Hashimoto encephalopathy: Syndrome or myth? Arch Neurol 2003;60(2):164-71.

5. Sawka AM, Fatourechi V, Boeve VH. Rarity of encephalopathy associated with autoimmune thyroiditis: A series from Mayo Clinic from 1950 to1996. Thyroid 2002;12(5):393-8.

6. Blanchin S, Cofin C, Viader F. Anti-thyroperoxidase antibodies from patients with Hashimoto's encephalopathy bind to cerebellar astrocytes. J Neuroimmunol. 2007;192(1-2):13-20.

7. Marshall GA, Doyle JJ. Long term treatment of Hashimoto's encephalopathy. J Neuropsychiatry Clin Neurosci 2006;18(1):14-20.

8. Chen PL, Wang PY, Hsu HY. Reversible electroencephalographic and single photon emission computed tomography abnormalities in Hashimoto's encephalopathy. J Chin Med Assoc. 2005; 68(2):77-81.

9. Castillo P, Woodruf B, Caselli R. Steroid responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol 2006;63(2):197-202.

10. Ferracci F, Bertiato G, Moretto G. Hashimoto's encephalopathy: epidemiologic data and pathogenetic considerations. J Neurol Sci 2004, 217(2):165-8.

11. Kishitani T,Matsunaga A,Yoneda M. The biomarker and treatment in Hashimoto's encephalopahty Nihon Rinsho 2013 ;71(5):893-7.

12. Yuceyar N, Karadeniz M, Copur A. Thyrotoxic autoimmune encephalopathy in a female patient: only partial response to typical immunosuppressant treatment and remission after thyroidectomy. Clin Neurol Neurosurg 2007;109(5):458-62.

13. Mocellin R, Lubman DI, Lloyd J. Reversible dementia with psychosis: Hashimoto's encephalopathy. Psychiatry Clin Neurosci 2006;60(6):761-3 14. Tzakas P, Sit SW. Progressive impairment of cognition and motor function: Hashimoto encephalopathy. CMAJ 2011; 183(8);495-7.

Any information missing or wrong?Report an Issue